Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Pancreatitis

Free Subscription Articles published in Proc Natl Acad Sci U S A Retrieve available abstracts of 28 articles: HTML format

Single Articles

June 2026
1. JANG I, Duffey A, Itkin-Ansari P, Arvan P, et al
   Coordinated expression and assembly of BiP, p58(IPK), and ER chaperone complexes maximize proinsulin folding in pancreatic beta cells.
   Proc Natl Acad Sci U S A. 2026;123:e2533617123.
   PubMed     Abstract available
   
   
   
2. LIAKI V, Barrambana S, Kostopoulou M, Lechuga CG, et al
   A targeted combination therapy achieves effective pancreatic cancer regression and prevents tumor resistance.
   Proc Natl Acad Sci U S A. 2026;123:e2610708123.
   PubMed     Abstract available
   
   
   May 2026
3. TESTA E, Dezi C, Lovat F, Piro G, et al
   Fra-2 controls the response to the KRAS inhibitor MRTX-1133 in pancreatic ductal adenocarcinoma.
   Proc Natl Acad Sci U S A. 2026;123:e2601788123.
   PubMed     Abstract available
   
   
   
4. MILCAREK AT, Yeon M, Esposito C, Kulkarni P, et al
   Mitochondrial double-stranded RNA fuels pancreatic cancer growth via RIG-I/TLR3 inflammation.
   Proc Natl Acad Sci U S A. 2026;123:e2528281123.
   PubMed     Abstract available
   
   
   
5. 
   Retraction for Liaki et al., A targeted combination therapy achieves effective pancreatic cancer regression and prevents tumor resistance.
   Proc Natl Acad Sci U S A. 2026;123:e2612385123.
   PubMed    
   
   
   March 2026
6. RAMSEY EL, Dobersch S, Freie B, Hong NH, et al
   MondoA mediates transcriptional coordination between the MYC network and the integrated stress response in pancreatic cancer.
   Proc Natl Acad Sci U S A. 2026;123:e2524659123.
   PubMed     Abstract available
   
   
   February 2026
7. ZHAO H, Chen H, Kang Z, Huang X, et al
   Genetic recording of pancreatic beta cell proliferation.
   Proc Natl Acad Sci U S A. 2026;123:e2507877123.
   PubMed     Abstract available
   
   
   January 2026
8. ANTONUCCI L, Watari K, Feng Y, Qi J, et al
   Selective targeting of NRF2-high pancreatic ductal adenocarcinoma with an NQO1-activatable prodrug.
   Proc Natl Acad Sci U S A. 2026;123:e2511733123.
   PubMed     Abstract available
   
   
   
9. LU H, Liu Y, Chiang HY, Zhang H, et al
   Exploring the interplay between protein conformational changes and phosphorylation in a pancreatic cancer cell and stellate cell coculture system.
   Proc Natl Acad Sci U S A. 2026;123:e2511839122.
   PubMed     Abstract available
   
   
   December 2025
10. LIAKI V, Barrambana S, Kostopoulou M, Lechuga CG, et al
    A targeted combination therapy achieves effective pancreatic cancer regression and prevents tumor resistance.
    Proc Natl Acad Sci U S A. 2025;122:e2523039122.
    PubMed     Abstract available
    
    
    November 2025
11. LI YR, Shen X, Zhu E, Li Z, et al
    Targeting orthotopic and metastatic pancreatic cancer with allogeneic stem cell-engineered mesothelin-redirected CAR-NKT cells.
    Proc Natl Acad Sci U S A. 2025;122:e2517786122.
    PubMed     Abstract available
    
    
    
12. YANG X, Wang Y, Zhou J, Li S, et al
    Engineering a spatiotemporal macrophage circuit via STING phase separation to override immune suppression in pancreatic cancer.
    Proc Natl Acad Sci U S A. 2025;122:e2504718122.
    PubMed     Abstract available
    
    
    September 2025
13. CHUANG PK, Chung C, Liao KS, Wong CH, et al
    Improving the efficacy of anti-SSEA4 antibody in pancreatic cancer immunotherapy with glyco-optimization and immune checkpoint blockade.
    Proc Natl Acad Sci U S A. 2025;122:e2517415122.
    PubMed     Abstract available
    
    
    August 2025
14. YUAN S, Yang X, Bremmer AM, Wang Y, et al
    Programmable immunoprobiotics orchestrate antitumor immune response with Pin1 inhibition for pancreatic cancer treatment.
    Proc Natl Acad Sci U S A. 2025;122:e2507711122.
    PubMed     Abstract available
    
    
    July 2025
15. MORESCO P, Kastan JP, Yang JI, Prabakar R, et al
    Signal peptide-independent secretion of keratin-19 by pancreatic cancer cells.
    Proc Natl Acad Sci U S A. 2025;122:e2426218122.
    PubMed     Abstract available
    
    
    April 2025
16. VINAIXA J, Martinez-Bosch N, Gibert J, Manero-Ruperez N, et al
    Nuclear Galectin-1 promotes KRAS-dependent activation of pancreatic cancer stellate cells.
    Proc Natl Acad Sci U S A. 2025;122:e2424051122.
    PubMed     Abstract available
    
    
    March 2025
17. ZHU Q, Yu C, Chen Y, Luo W, et al
    Dual mRNA nanoparticles strategy for enhanced pancreatic cancer treatment and beta-elemene combination therapy.
    Proc Natl Acad Sci U S A. 2025;122:e2418306122.
    PubMed     Abstract available
    
    
    October 2024
18. YANG Y, Wang B, Dong H, Lin H, et al
    The mitochondrial enzyme pyruvate carboxylase restricts pancreatic beta-cell senescence by blocking p53 activation.
    Proc Natl Acad Sci U S A. 2024;121:e2401218121.
    PubMed     Abstract available
    
    
    August 2024
19. KITAMURA RA, Hummel D, Ustione A, Piston DW, et al
    Dual role of neuroplastin in pancreatic beta cells: Regulating insulin secretion and promoting islet inflammation.
    Proc Natl Acad Sci U S A. 2024;121:e2411234121.
    PubMed     Abstract available
    
    
    
20. SU W, Kochen Rossi J, Nuevo-Tapioles C, Chen T, et al
    UPF1 deficiency enhances mitochondrial ROS which promotes an immunosuppressive microenvironment in pancreatic ductal adenocarcinoma.
    Proc Natl Acad Sci U S A. 2024;121:e2401996121.
    PubMed     Abstract available
    
    
    July 2024
21. AMIT U, Uslu U, Verginadis II, Kim MM, et al
    Proton radiation boosts the efficacy of mesothelin-targeting chimeric antigen receptor T cell therapy in pancreatic cancer.
    Proc Natl Acad Sci U S A. 2024;121:e2403002121.
    PubMed     Abstract available
    
    
    
22. LI J, Moresco P, Fearon DT
    Intratumoral NKT cell accumulation promotes antitumor immunity in pancreatic cancer.
    Proc Natl Acad Sci U S A. 2024;121:e2403917121.
    PubMed     Abstract available
    
    
    April 2024
23. HIYOSHI H, Sakuma K, Asano S, Napier SC, et al
    Identification and removal of unexpected proliferative off-target cells emerging after iPSC-derived pancreatic islet cell implantation.
    Proc Natl Acad Sci U S A. 2024;121:e2320883121.
    PubMed     Abstract available
    
    
    
24. MURTHY D, Attri KS, Suresh V, Rajacharya GH, et al
    The MUC1-HIF-1alpha signaling axis regulates pancreatic cancer pathogenesis through polyamine metabolism remodeling.
    Proc Natl Acad Sci U S A. 2024;121:e2315509121.
    PubMed     Abstract available
    
    
    August 2023
25. DASGUPTA A, Gibbard DF, Schmitt RE, Arneson-Wissink PC, et al
    A TGF-beta/KLF10 signaling axis regulates atrophy-associated genes to induce muscle wasting in pancreatic cancer.
    Proc Natl Acad Sci U S A. 2023;120:e2215095120.
    PubMed     Abstract available
    
    
    May 2023
26. CHANDA D, Thoudam T, Sinam IS, Lim CW, et al
    Upregulation of the ERRgamma-VDAC1 axis underlies the molecular pathogenesis of pancreatitis.
    Proc Natl Acad Sci U S A. 2023;120:e2219644120.
    PubMed     Abstract available
    
    
    March 2023
27. 
    Correction for Taylor et al., Human pancreatic islet microRNAs implicated in diabetes and related traits by large-scale genetic analysis.
    Proc Natl Acad Sci U S A. 2023;120:e2302726120.
    PubMed    
    
    
    
28. MELLO SS, Flowers BM, Mazur PK, Lee JJ, et al
    Multifaceted role for p53 in pancreatic cancer suppression.
    Proc Natl Acad Sci U S A. 2023;120:e2211937120.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Pancreatitis is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum